Series A2 unread notifications
Josh Wolfe co-founded Lux Capital to back scientists and entrepreneurs developing ideas outside the consensus. His work connects science, company formation and markets, following earlier roles in investment banking at Salomon Smith Barney, capital markets at Merrill Lynch, and municipal finance at Prudential Securities.
Josh Wolfe co-founded Lux Capital to back scientists and entrepreneurs developing ideas outside the consensus. His work connects science, company formation and markets, following earlier roles in investment banking at Salomon Smith Barney, capital markets at Merrill Lynch, and municipal finance at Prudential Securities.
Career
Josh Wolfe studied at Cornell University (B.S. in Economics and Finance (1999)).
Co-founder and Managing Partner at Lux Capital from 2000 to PresentCo-founded and helps lead the venture firm, focusing on science- and technology-driven companies across sectors including defense, biotechnology, energy, computing and robotics.
Trustee at Santa Fe Institute until PresentATBoard Director at Aera Therapeutics until PresentServes on the board of the genetic-medicines company.
KBoard Director at Kallyope until PresentServes on the company’s board of directors.
VBBoard Director at Variant Bio until PresentServes on the board; co-founded Variant Bio in 2018 with Kaja Wasik and Stephane Castel.
OBoard Director at Osmo until PresentServes on the board of Osmo, which develops technology for digitizing smell.
ETBoard Director at Eikon Therapeutics until 2026-07Served on the board until resigning on July 31, 2026.
CIChairman at Coney Island Prep until 2024-08Co-founded the school and chaired its board of trustees through August 2024.
SHBoard Director at Shapeways Holdings, Inc. until 2024-07Served on the board until resigning with the other directors when the company filed for bankruptcy on July 2, 2024.
KCo-founder at Kurion from 2008 to 2016
